D&D Pharmatech Inc. (KOSDAQ:347850)
South Korea · Delayed Price · Currency is KRW 97,700
+2,800 (2.95%)
At close: Dec 29, 2025
D&D Pharmatech Market Cap
D&D Pharmatech has a market cap or net worth of 4.24 trillion as of December 30, 2025. Its market cap has increased by 922.68% in one year.
Market Cap
4.24T
Enterprise Value
4.21T
Revenue
8.36B
Ranking
n/a
PE Ratio
n/a
Stock Price
97,700.00
Market Cap Chart
Since May 2, 2024, D&D Pharmatech's market cap has increased from 379.56B to 4.24T, an increase of 1,017.78%. That is a compound annual growth rate of 327.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 29, 2025 | 4.24T | 726.05% |
| Dec 30, 2024 | 513.61B | 35.32% |
| May 2, 2024 | 379.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 78.32T |
| Celltrion | 39.38T |
| ALTEOGEN | 23.48T |
| ABL Bio | 10.97T |
| SK Biopharmaceuticals | 9.80T |
| Yuhan | 8.41T |
| LigaChem Biosciences | 6.55T |
| HLB Co., Ltd. | 6.06T |